Brain clinical trials

Explore recruiting brain clinical trials.

Recruiting brain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Brain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02D

Hungary, Poland, Greece, Spain, Italy, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placebo-controlled randomized clinical trial (MACSiMiSE-BRAIN)

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Clear-Brain: stimulating amyloid clearance in cerebral amyloid angiopathy

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of p-glycoprotein alterations in treatment-resistant depression: a [18F]MC225 PET study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

SGM-CBM: A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of colorectal brain metastases.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Single-arm, Open-label Extension of the Vericiguat VALOR Study in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR EXT)

Italy, Portugal, Sweden, Denmark, Poland, Belgium +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Brain trials by city

Brain in Toronto Brain in Vancouver Brain in Montreal Brain in Calgary Brain in Edmonton Brain in Ottawa Brain in Winnipeg Brain in Quebec City Brain in Hamilton Brain in Kitchener Brain in London Brain in Halifax Brain in New York Brain in Los Angeles Brain in Chicago Brain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease